Supporting HIV care through education and innovation

Drugs That Fight HIV Brochure Updated by NIAID

Drugs That Fight HIV Brochure Updated by NIAID

Monday, July 29, 2013

AIDSInfo

Description

NIAID recently updated the "Drugs That Fight HIV" brochure, which features images of FDA-approved antiretroviral medications, grouped by drug class and clearly identified by both generic and brand names. The brochure can be used by health care professionals when discussing HIV treatment with patients.

The brochure includes the addition of three drugs:

  • Rilpivirine (brand name: Edurant), a non-nucleoside reverse transcriptase inhibitor (NNRTI), approved May 2011.
  • Emtricitabine/rilpivirine/tenofovir (brand name: Complera), a combination drug, approved August 2011.
  • Elvitegravir/cobicistat/emtricitabine/tenofovir (brand name: Stribild), a combination drug, approved August 2012.

Other additions include brief descriptions of each drug class and new drug formulations with accompanying images.

Add a Comment

Log in or register to post comments